Seeking Alpha

Marty Chilberg's  Instablog

Marty Chilberg
Send Message
I'm a retired CPA who spent the majority of his working career in technology companies. My work included management stints at Atari Inc, Daisy Systems Corp, Symantec Corp and Visio Corp. My last position at Visio (VSIO) was as CFO and VP Finance and Operations.
  • NPS Pharmaceuticals: Upgrade Lost In The Macro News 2 comments
    Aug 16, 2014 11:52 AM | about stocks: NPSP

    NPSP is one of my bio basket investments but I'm looking to add to it and make it a full investment position. On Friday the stock didn't move much given FBR Capital initiating coverage with an overweight rating. Company is transitioning to a profitable entity with minimal dilution risk. Gattex is currently showing solid sales and a 2nd drug, Natpara is in stage 3 clinical trials with possible FDA approval by end of this year. Additional information will be posted here.

    Disclosure: The author is long NPSP.

    Themes: biotechnology Stocks: NPSP
Back To Marty Chilberg's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • tradingoptions3
    , contributor
    Comments (4) | Send Message
     
    Marty,

     

    Any visibility on the price action of NPSP for the rest of 2014 (conservative and aggressive targets) given a Natpara approval. I expect a slight move up before Adcom in mid september but beyond that I am a bit stumped.

     

    Thanks
    TO3
    18 Aug 2014, 05:43 AM Reply Like
  • Marty Chilberg
    , contributor
    Comments (422) | Send Message
     
    Author’s reply » I'm not very good at picking stock price targets for bio plays. The upside movement is dictated by momentum player as well as short covering and typically doesn't follow any real fundamental analysis. GIven the previous high around $40 and the high price target by analysts of $44, it wouldn't surprise me to see the exceed both of these with a Natpara approval and any incremental good news on pipeline.
    18 Aug 2014, 07:17 AM Reply Like
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.